Gene · 3376
Papers2,904
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,904
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular aspects of the exercise response and training adaptation in skeletal muscle. | Free Radic Biol Med | 2024 | 39059515 | PubTator, text mining | PubMed |
| Enzymatic Fructosylation of Phenolic Compounds: A New Alternative for the Development of Antidiabetic Drugs. | Molecules | 2024 | 38999025 | PubTator, text mining | PubMed |
| Mitogen signaling strength and duration can control cell cycle decisions. | Sci Adv | 2024 | 38968359 | PubTator, text mining | PubMed |
| Circular RNA IARS modulates the progression and ferroptosis of osteosarcoma via sponging miR-188-5p from RAB14. | Neoplasma | 2024 | 38958715 | PubTator, text mining | PubMed |
| Severe finger necrosis in antisynthetase syndrome with positive anti-OJ antibodies. | Clin Case Rep | 2024 | 38831985 | PubTator, text mining | PubMed |
| Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance. | Cancer Res | 2024 | 38775809 | PubTator, text mining | PubMed |
| Mitochondria targeted esculetin administration improves insulin resistance and hyperglycemia-induced atherosclerosis in db/db mice. | J Mol Med (Berl) | 2024 | 38758435 | PubTator, text mining | PubMed |
| Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease. | Cell Metab | 2024 | 38718757 | PubTator, text mining | PubMed |
| Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2. | Sci Rep | 2024 | 38671227 | PubTator, text mining | PubMed |
| Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease. | J Alzheimers Dis | 2024 | 38607755 | PubTator, text mining | PubMed |
| Receptor-Assisted Nanotherapeutics for Overcoming the Blood-Brain Barrier. | Mol Neurobiol | 2024 | 38558360 | PubTator, text mining | PubMed |
| NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma. | Hematol Transfus Cell Ther | 2024 | 38523043 | PubTator, text mining | PubMed |
| Correction to "Gly56 in the synthetic site of isoleucyl-tRNA synthetase confers specificity and maintains communication with the editing site". | FEBS Lett | 2024 | 38351625 | PubTator, text mining | PubMed |
| Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus. | Int J Mol Sci | 2024 | 38279313 | PubTator, text mining | PubMed |
| Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer. | NPJ Precis Oncol | 2024 | 38273040 | PubTator, text mining | PubMed |
| An artificial neural network model for evaluating the risk of hyperuricaemia in type 2 diabetes mellitus. | Sci Rep | 2024 | 38273015 | PubTator, text mining | PubMed |
| The hypothalamic-pituitary-thyroid axis is intact in male insulin receptor substrate 4 knockout mice. | Eur Thyroid J | 2024 | 38271814 | PubTator, text mining | PubMed |
| Targeting the Metabolic Paradigms in Cancer and Diabetes. | Biomedicines | 2024 | 38255314 | PubTator, text mining | PubMed |
| Shared Genetics between Age at Menarche and Type 2 Diabetes Mellitus: Genome-Wide Genetic Correlation Study. | Biomedicines | 2024 | 38255262 | PubTator, text mining | PubMed |
| Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins. | Cancers (Basel) | 2024 | 38254802 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3376/papers?page=10